Smith-Jeffcoat, S. E., Biddle, J. E., Talbot, H. K., Morrissey, K. G., Stockwell, M. S., Maldonado, Y., McLean, H. Q., Ellingson, K. D., Bowman, N. M., Asturias, E., Mellis, A. M., Johnson, S., Kirking, H. L., Rolfes, M. A. R., Olivo, V., Merrill, L., Battan-Wraith, S., Sano, E., McLaren, S. H., … Salvatore, P. P. (2023). Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched Untreated Individuals. Clinical Infectious Diseases, 78(5), 1175–1184. https://doi.org/10.1093/cid/ciad696

Salerno, D. M., Jennings, D. L., Lange, N. W., Kovac, D. (Bley), Shertel, T., Chen, J. K., Hedvat, J., Scheffert, J., Brown Jr, R. S., & Pereira, M. R. (2022). Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients. American Journal of Transplantation, 22(8), 2083–2088. https://doi.org/10.1111/ajt.17027